Han Li’s study connects overexpression of KIF20A in epithelial ovarian cancer with advanced stages, metastasis, recurrence, and chemoresistance, establishing it as a significant independent risk marker and promising prognostic biomarker [31]. The gene discussed is KIF20A; the disease is ovarian carcinoma.